F.T.C. Criticizes Agreements That Delay Generic Drugs
Wednesday, August 31, 2011 - 19:20
in Mathematics & Economics
The Federal Trade Commission denounced “sweetheart deals” in which some drug makers promise not to introduce their own generic versions if a potential competitor delays its entry into the market.